Clinical trials
Completed Observational Bites and Stings trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angiodynamics, Inc. | 1 |
| Aydin Adnan Menderes University | 1 |
| Bezmialem Vakif University | 1 |
| Centre Hospitalier Régional d'Orléans | 1 |
| Centre Hospitalier Sud Francilien | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Clinical Centre of Serbia | 1 |
| Diskapi Yildirim Beyazit Education and Research Hospital | 1 |
| Dr. Ersin Arslan Education and Training Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bites and Stings | 35 |
| Cardiomyopathy, Hypertrophic | 3 |
| Agnosia | 2 |
| Arterial Occlusive Diseases | 2 |
| Pain | 2 |
| Temporomandibular Joint Disorders | 2 |
| Alzheimer Disease | 1 |
| Aneurysm | 1 |
| Breast Neoplasms | 1 |
| Cardiomegaly | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.